Published in:
01-12-2021 | Adrenalectomy | Endocrine Tumors
Volume Matters: Longitudinal Retrospective Cohort Study of Outcomes Following Consolidation and Standardization of Adrenal Surgery
Published in: Annals of Surgical Oncology | Issue 13/2021
Login to get accessAbstract
Purpose
Subspecialization of adrenal surgery through regionalization has not been adequately evaluated. We assessed implementation of subspecialization and the association of regionalization with adrenalectomy outcomes in a community-based setting.
Methods
In this longitudinal retrospective cohort study, we used an interrupted time series analysis on consecutive adrenal surgeries at Kaiser Permanente Northern California, 2010–2019. The intervention was regionalization of surgery in 2016. Main outcomes include surgical volumes, operative time, length of stay, 30-day return-to-care, and 30-day complications obtained from the electronic medical record. t-Tests and multivariable models were used to analyze time trends in outcomes after accounting for changes in patient and disease characteristics.
Results
In total, 850 adrenal surgery cases were eligible. Between 2010 and 2019, the annual incidence of surgery (per 100,000 persons) increased from 2.4 (95% CI 1.9–3.1) to 4.1 (95% CI 3.5–4.8). Average annual surgeon volume increased from 2.4 (95% CI 1.6–3.1) to 9.9 (95% CI 4.9–14.9), while hospital volume increased from 3.5 (95% CI 2.3–4.6) to 15.4 (95% CI 6.9–24.0). Operative time was 34 (23–45) min faster in 2018–2019 compared with 2010–2011. After regionalization, same-day discharges increased to 64% in 2019 (p < 0.0001). The frequency of return-to-care (p = 0.69) and the overall complication rate (p = 0.31) did not change.
Conclusions
Regionalizing adrenal surgery through surgical subspecialization and standardized care pathways was feasible and decreased operative time, and hospital stay, while increasing the frequency of same-day discharges without increasing return-to-care or complications.